BURZYNSKI RESEARCH INSTITUTE INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data BURZYNSKI RESEARCH INSTITUTE INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	0	0	0	0	0	0	0	0	0	0
Research and development	1.85	1.32	1.28	1.15	1.2	1.02	0.76	0.72	0.86	1.05
General and administrative	0.16	0.18	0.33	0.49	0.43	0.28	0.22	0.2	0.47	0.34
Operating expenses	2.01	1.5	1.61	1.64	1.63	1.3	0.98	0.92	1.34	1.39
Operating income	-2.01	-1.5	-1.61	-1.64	-1.63	-1.3	-0.98	-0.92	-1.34	-1.39
Pre-tax income	-2.01	-1.5	-1.61	-1.64	-1.63	-1.2	-0.98	-0.92	-1.34	-1.39
Income tax	0				0	0	0	0	0	0
Net income	-2.01	-1.5	-1.61	-1.64	-1.63	-1.2	-0.98	-0.92	-1.34	-1.39
EBITDA	-2	-1.5	-1.61
EPS, basic	-0.02	-0.01	-0.01	-0.01	-0.01	-0.01	-0.01	-0.01	-0.01	-0.01
EPS, diluted	-0.02	-0.01	-0.01	-0.01	-0.01	-0.01	-0.01	-0.01	-0.01	-0.01
Shares, basic (weighted)	131	131	131	131	131	131	131	131	131	131
Shares, diluted (weighted)	131	131	131	131	131	131	131	131	131	131

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	0	0	0	0	0	0	0	0	0	0
Other current assets			0.03	0.02	0.02	0	0	0	0
Total current assets	0	0.01	0.03	0.02	0.02	0	0	0	0	0
Property, plant and equipment	0
Total assets	0	0.01	0.03	0.02	0.02	0	0	0	0	0
Accounts payable	0.06	0.02	0.04	0.1	0.06	0.03		0.01	0.01	0.02
Accrued liabilities	0.04	0.02	0.09	0.11	0.11	0.01	0	0	0.02	0.03
Total current liabilities	0.11	0.04	0.14	0.21	0.17	0.05
Total liabilities	0.11	0.04	0.14	0.21	0.17	0.05	0	0.02	0.03	0.04
Paid-in capital	117	119	120	122	123	125	126	127	128	129
Retained earnings	-117	-119	-120	-122	-124	-125	-126	-127	-128	-129
Shareholders' equity	-0.1	-0.03	-0.11	-0.19	-0.15	-0.05	0	-0.01	-0.03	-0.04
Total equity	-0.1	-0.03	-0.11	-0.19	-0.15	-0.05	0	-0.01	-0.03	-0.04
Total liabilities and equity	0	0.01	0.03	0.02	0.02	0	0	0	0	0
Shares outstanding	131	131	131	131	131	131	131	131	131	131

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	-2.01	-1.5	-1.61	-1.64	-1.63	-1.2	-0.98	-0.92	-1.34	-1.39
Depreciation and amortization	0	0	0
Change in payables	-0.04	-0.04	0.02	0.06	-0.04	-0.03	-0.03	0.01	-0	0.01
Cash from operations	-0.25	-0.31	-0.32	-0.48	-0.53	-0.39	-0.33	-0.25	-0.52	-0.39
Cash from financing	0.25	0.31	0.32	0.48	0.53	0.39	0.33	0.25	0.52	0.39
Net change in cash			-0	0	-0	-0	0	-0	0	-0
Interest paid		0.08	0.03
Income taxes paid		0	0

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to November 30, 2025; growth uses fiscal years. Valuation uses the share price of $0.00 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Return on assets (ROA)	-56,820.0%	Net income / average total assets.

Growth

Metric	Value	How it is calculated
Total assets growth, 1y	-63.3%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-43.4%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-46.8%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.0%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	0.0%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	0.0%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Liabilities / assets	3,073.0%	Total liabilities / total assets.
Tangible book value	-$67.3K	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.00x	Revenue / average total assets.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$0.01	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$0.00	Revenue / diluted weighted shares.
Operating cash flow per share	-$0.00	Cash from operations / diluted weighted shares.
Book value per share	-$0.00	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$0.00	Tangible book value / shares outstanding.
Cash per share	$0.00	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$262.9K	Share price x shares outstanding.
Enterprise value	$260.7K	Market cap + total debt - cash - short-term investments.
Earnings yield	-489.5%	Net income / market cap (the inverse of P/E).

What was BURZYNSKI RESEARCH INSTITUTE INC's revenue in fiscal 2025?

BURZYNSKI RESEARCH INSTITUTE INC reported revenue of $0.0 for fiscal 2025.

Was BURZYNSKI RESEARCH INSTITUTE INC profitable in fiscal 2025?

No. It reported a net loss of $1.4M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to BURZYNSKI RESEARCH INSTITUTE INC